Earnings Releases·Nov 13, 2026, 3:03 PM ET

Deep Isolation Nuclear, Inc. — Third Quarter 2026 Earnings Summary

Consolidated revenue increased 6% year-over-year to $1.8 million, while net loss widened to $3.8 million from $1.3 million in the prior year period, driven by a 74% surge in SG&A expenses to $4.3 million and the initiation of $0.5 million in R&D costs.
Cash and cash equivalents declined to $16.5 million as of September 30, 2026, down from $28.2 million a year prior, reflecting increased operational expenditures including the addition of nine new employees.
The Commercialization Pilot near Cameron, Texas, advanced with the receipt of a drilling permit and commencement of well pad construction subsequent to the quarter-end, alongside selection as the sole industrial partner on three DOE Project GENESIS grants.
Management highlighted progress toward commercial readiness but emphasized that full commercialization remains contingent on successful technology demonstration, regulatory licensing, financing, and legislative changes.
No specific financial guidance or capital return announcements were provided; the company continues to operate as a pre-revenue commercialization entity with stock trading on the OTCQB Venture Market under "DBHL."